Puts Purchased on Myriad Genetics

Shares of Myriad Genetics MYGN are lower on the session by 0.08%, currently trading at $23.69. The stock has been moving largely higher over the past four months and is currently trading above the 50-day moving average. Options traders are buying puts on the name today. A short while ago the July 2011 $24.00 put traded 900 times on open interest of 785 contracts. Overall put volume is now running at 4.09x the daily average with 97% of all puts traded being purchases on the offer. Myriad Genetics, Inc. is a molecular diagnostic company focused on developing and marketing novel predictive medicine, personalized medicine and prognostic medicine products.